Joint statement in support of hepatitis C human challenge studies

Affiliations

• ¹ Transfusion Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA.
• ² Nuffield Department of Medicine, University of Oxford, Oxford, UK.
• ³ School of Nursing, York University, Toronto, ON, Canada.
• ⁴ The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ⁵ 1Day Sooner, Washington, DC, 20002, USA, University of Toronto, Toronto, ON, Canada. Electronic address: jake.eberts@1daysooner.org.
• ⁶ Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, ON, Canada.
• ⁷ Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
• ⁸ 1Day Sooner, Claymont, DE, USA.
• ⁹ Laboratory of Virology and Infectious Disease, Rockefeller University, New York, NY, USA; Departments of Medicine and of Microbiology and Immunology, Université de Montréal, Montréal, QC, Canada.
• ¹⁰ Laboratory of Liver Immunology, University of Montreal Hospital Research Centre (CRCHUM), Montréal, QC, Canada.
• ¹¹ Action Hepatitis Canada, Montréal, QC, Canada.
• ¹² Departments of Philosophy, Medicine, and Epidemiology and Biostatistics, Western University, London, ON, Canada.